| A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases |
69 |
| Obesity Increases the Duration of Influenza A Virus Shedding in Adults |
46 |
| Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity |
36 |
| Human Coronavirus in Hospitalized Children With Respiratory Tract Infections: A 9-Year Population-Based Study From Norway |
31 |
| Outbreak Investigation of Nipah Virus Disease in Kerala, India, 2018 |
30 |
| Increased Risk of HIV Acquisition Among Women Throughout Pregnancy and During the Postpartum Period: A Prospective Per-Coital-Act Analysis Among Women With HIV-Infected Partners |
29 |
| The Economic and Social Burden of the 2014 Ebola Outbreak in West Africa |
29 |
| High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection |
28 |
| Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection |
27 |
| Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes |
26 |
| Human Coronavirus NL63 Molecular Epidemiology and Evolutionary Patterns in Rural Coastal Kenya |
25 |
| Therapeutic Implications of Human Umbilical Cord Mesenchymal Stromal Cells in Attenuating Influenza A( H5N1) Virus-Associated Acute Lung Injury |
25 |
| The Impact of Rotavirus Vaccines on Genotype Diversity: A Comprehensive Analysis of 2 Decades of Australian Surveillance Data |
24 |
| Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania |
24 |
| A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model |
23 |
| Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018 |
22 |
| Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older |
21 |
| An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis |
21 |
| Lung-Derived Exosomal miR-483-3p Regulates the Innate Immune Response to Influenza Virus Infection |
21 |
| Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates |
21 |
| Rat Hepatitis E Virus Linked to Severe Acute Hepatitis in an Immunocompetent Patient |
21 |
| Longitudinal Analysis of Antibody Cross-neutralization Following Zika Virus and Dengue Virus Infection in Asia and the Americas |
21 |
| Protection of the Human Gut Microbiome From Antibiotics |
20 |
| Respiratory Syncytial Virus Seasonality: A Global Overview |
19 |
| Histo-Blood Group Antigen Phenotype Determines Susceptibility to Genotype-Specific Rotavirus Infections and Impacts Measures of Rotavirus Vaccine Efficacy |
19 |
| Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects |
19 |
| Evaluation of the Xpert HCV Viral Load Finger-Stick Point-of-Care Assay |
19 |
| Infection Rates and Risk Factors for Infection Among Health Workers During Ebola and Marburg Virus Outbreaks: A Systematic Review |
18 |
| The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV Delta G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak |
18 |
| Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors |
17 |
| Candidalysin Is Required for Neutrophil Recruitment and Virulence During Systemic Candida albicans Infection |
17 |
| Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient |
17 |
| Global Cholera Epidemiology: Opportunities to Reduce the Burden of Cholera by 2030 |
17 |
| The Impact of Unconscious Bias in Healthcare: How to Recognize and Mitigate It |
17 |
| Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18-to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination |
16 |
| Receptor Usage of a Novel Bat Lineage C Betacoronavirus Reveals Evolution of Middle East Respiratory Syndrome-Related Coronavirus Spike Proteins for Human Dipeptidyl Peptidase 4 Binding |
16 |
| Opioids and Infectious Diseases: A Converging Public Health Crisis |
16 |
| Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B |
16 |
| Bivalent Human Papillomavirus Vaccine Effectiveness in a Japanese Population: High Vaccine-TypeSpecific Effectiveness and Evidence of Cross-Protection |
16 |
| Human Cytomegalovirus Genomes Sequenced Directly From Clinical Material: Variation, Multiple-Strain Infection, Recombination, and Gene Loss |
15 |
| Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay |
15 |
| Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective Study |
15 |
| Asymptomatic Natural Human Infections With the Simian Malaria Parasites Plasmodium cynomolgi and Plasmodium knowlesi |
15 |
| Integrating Facility-Based Surveillance With Healthcare Utilization Surveys to Estimate Enteric Fever Incidence: Methods and Challenges |
15 |
| Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis |
15 |
| Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis |
15 |
| An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the Perfect Storm |
15 |
| Anti-Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease |
15 |
| Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya |
14 |
| Quantification of Torque Teno Virus Viremia as a Prospective Biomarker for Infectious Disease in Kidney Allograft Recipients |
14 |
